These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15130801)

  • 1. MAPPP: MHC class I antigenic peptide processing prediction.
    Hakenberg J; Nussbaum AK; Schild H; Rammensee HG; Kuttler C; Holzhütter HG; Kloetzel PM; Kaufmann SH; Mollenkopf HJ
    Appl Bioinformatics; 2003; 2(3):155-8. PubMed ID: 15130801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHCPred: bringing a quantitative dimension to the online prediction of MHC binding.
    Guan P; Doytchinova IA; Zygouri C; Flower DR
    Appl Bioinformatics; 2003; 2(1):63-6. PubMed ID: 15130834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods and protocols for prediction of immunogenic epitopes.
    Tong JC; Tan TW; Ranganathan S
    Brief Bioinform; 2007 Mar; 8(2):96-108. PubMed ID: 17077136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ProPred1: prediction of promiscuous MHC Class-I binding sites.
    Singh H; Raghava GP
    Bioinformatics; 2003 May; 19(8):1009-14. PubMed ID: 12761064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes.
    Brown MG; Driscoll J; Monaco JJ
    Nature; 1991 Sep; 353(6342):355-7. PubMed ID: 1922341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from MHC-bound peptides.
    Margalit H; Altuvia Y
    Novartis Found Symp; 2003; 254():77-90; discussion 91-101, 216-22, 250-2. PubMed ID: 14712933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
    Vinitsky A; Antón LC; Snyder HL; Orlowski M; Bennink JR; Yewdell JW
    J Immunol; 1997 Jul; 159(2):554-64. PubMed ID: 9218569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
    Rock KL; York IA; Goldberg AL
    Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.
    Khattab B; Eiz-Vesper B; Ganser A; Hertenstein B; Blasczyk R
    Ann Hematol; 2004 Feb; 83(2):107-13. PubMed ID: 14648025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
    Teoh CY; Davies KJ
    Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI31 is a modulator of proteasome formation and antigen processing.
    Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative online prediction of peptide binding to the major histocompatibility complex.
    Hattotuwagama CK; Guan P; Doytchinova IA; Zygouri C; Flower DR
    J Mol Graph Model; 2004 Jan; 22(3):195-207. PubMed ID: 14629978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading.
    Benham AM; Grommé M; Neefjes J
    J Immunol; 1998 Jul; 161(1):83-9. PubMed ID: 9647210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural plasticity of the proteasome and its function in antigen processing.
    Groettrup M; van den Broek M; Schwarz K; Macagno A; Khan S; de Giuli R; Schmidtke G
    Crit Rev Immunol; 2001; 21(4):339-58. PubMed ID: 11922078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient peptide-MHC-I binding prediction for alleles with few known binders.
    Jacob L; Vert JP
    Bioinformatics; 2008 Feb; 24(3):358-66. PubMed ID: 18083718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.
    Strehl B; Seifert U; Krüger E; Heink S; Kuckelkorn U; Kloetzel PM
    Immunol Rev; 2005 Oct; 207():19-30. PubMed ID: 16181324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.